A Study Evaluating ABI-H0731 as Adjunctive Therapy in Participants With Chronic Hepatitis B Infection
Completed · Phase 2 · Has a placebo group
Conditions studied: Chronic Hepatitis B
In brief
The purpose of this study is to determine if ABI-H0731 given in combination with a standard of care (SOC) hepatitis B virus (HBV) nucleos(t)ide reverse transcriptase inhibitor (NUC) medication is safe and effective in participants with chronic hepatitis B virus infection (cHBV).
Key facts
- Study ID
- NCT03576066
- Run by
- Assembly Biosciences
- People needed
- 73
- Starts
- 2018-06-11
- Expected to finish
- 2019-07-05
- Last updated by the study team
- 2021-02-17
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Cedars-Sinai Medical Center — Beverly Hills, California, United States
- Southern California Research Center — Coronado, California, United States
- Asia Pacific Liver Center — Los Angeles, California, United States
- University of California Los Angeles — Los Angeles, California, United States
- Research and Education — San Diego, California, United States
- Medical Associates Research Group — San Diego, California, United States
- Quest Clinical Research — San Francisco, California, United States
- Stanford University Medical Center — Stanford, California, United States
- University of Miami Hospital and Clinics — Miami, Florida, United States
- Johns Hopkins University School of Medicine — Baltimore, Maryland, United States
- Digestive Disease Associates — Catonsville, Maryland, United States
- Infectious Disease Care — Hillsborough, New Jersey, United States
- Sing Chan, MD — Flushing, New York, United States
- NYU Langone Health — New York, New York, United States
- Icahn School of Medicine at Mount Sinai — New York, New York, United States
- Thomas Jefferson University Hospital — Philadelphia, Pennsylvania, United States
- Xiaoli Ma, MD — Philadelphia, Pennsylvania, United States
- Toronto General Hospital — Toronto, Canada
- Toronto Liver Center — Toronto, Canada
- GI Research Institute — Vancouver, Canada
- Auckland City Hospital — Auckland, New Zealand
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.